STRIPAK Members Orchestrate Hippo and Insulin Receptor Signaling to Promote Neural Stem Cell Reactivation

Adult stem cells reactivate from quiescence to maintain tissue homeostasis and in response to injury. How the underlying regulatory signals are integrated is largely unknown. Drosophila neural stem cells (NSCs) also leave quiescence to generate adult neurons and glia, a process that is dependent on...

Full description

Saved in:
Bibliographic Details
Published inCell reports (Cambridge) Vol. 27; no. 10; pp. 2921 - 2933.e5
Main Authors Gil-Ranedo, Jon, Gonzaga, Eleanor, Jaworek, Karolina J, Berger, Christian, Bossing, Torsten, Barros, Claudia S
Format Journal Article
LanguageEnglish
Published United States Cell Press 04.06.2019
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Adult stem cells reactivate from quiescence to maintain tissue homeostasis and in response to injury. How the underlying regulatory signals are integrated is largely unknown. Drosophila neural stem cells (NSCs) also leave quiescence to generate adult neurons and glia, a process that is dependent on Hippo signaling inhibition and activation of the insulin-like receptor (InR)/PI3K/Akt cascade. We performed a transcriptome analysis of individual quiescent and reactivating NSCs harvested directly from Drosophila brains and identified the conserved STRIPAK complex members mob4, cka, and PP2A (microtubule star, mts). We show that PP2A/Mts phosphatase, with its regulatory subunit Widerborst, maintains NSC quiescence, preventing premature activation of InR/PI3K/Akt signaling. Conversely, an increase in Mob4 and Cka levels promotes NSC reactivation. Mob4 and Cka are essential to recruit PP2A/Mts into a complex with Hippo kinase, resulting in Hippo pathway inhibition. We propose that Mob4/Cka/Mts functions as an intrinsic molecular switch coordinating Hippo and InR/PI3K/Akt pathways and enabling NSC reactivation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Lead Contact
Sanofi Aventis Deutschland GmbH, 55126 Mainz, Germany
Present address: Living Systems Institute, University of Exeter, EX4 4QD Exeter, UK
These authors contributed equally
ISSN:2211-1247
2211-1247
DOI:10.1016/j.celrep.2019.05.023